RIMBP2 antisense RNA 1 (RIMBP2-AS1)

RIMBP2 antisense RNA 1 (RIMBP2-AS1) is a long non-coding RNA (lncRNA) gene transcribed antisense to the RIMBP2 locus, but its explicit functional role, disease relevance, and molecular/cellular mechanisms are not established in current gene annotation resources[1]. As a lncRNA, it may play a regulatory function at the RNA level, but it is not characterized as a receptor, enzyme, transporter, or established therapeutic target. No known pharmacological modulators, disease roles, or biomarker applications are reported[1]. Key clarifications: - RIMBP2-AS1 is not the same as RIMBP2 (RIMS binding protein 2), which is a synaptic protein involved in neuronal calcium channel regulation and neurotransmission[7]. - No evidence suggests RIMBP2-AS1 is currently considered a therapeutic target, nor does it have validated aliases beyond its systematic name[1]. - There are no documented drugs, safety concerns, or mechanisms of action associated specifically with RIMBP2-AS1 as of September 2025[1]. If any part of the query was actually meant to refer to RIMBP2 (the protein-coding gene), further clarification is needed; otherwise, all structured target information above pertains specifically to the non-coding RNA RIMBP2-AS1, consistent with current annotation[1].

Other names

RIMBP2-AS1RIMBP2 Antisense RNA 1